BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35481321)

  • 1. Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.
    Christensen BR; Rendo MJ; Beeler BW; Huddleston BJ; Fenderson JL
    Cureus; 2022 Mar; 14(3):e23398. PubMed ID: 35481321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report.
    Faiq S; Lavelle K; Hu T; Shoback D; Ku G
    BMC Endocr Disord; 2023 Jun; 23(1):133. PubMed ID: 37328745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcemia of Malignancy and Colorectal Cancer.
    Galindo RJ; Romao I; Valsamis A; Weinerman S; Harris YT
    World J Oncol; 2016 Feb; 7(1):5-12. PubMed ID: 26998187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual case of malignancy-related hypercalcemia.
    Doyle MA; Malcolm JC
    Int J Gen Med; 2013; 7():21-7. PubMed ID: 24353437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review.
    Sheehan M; Tanimu S; Tanimu Y; Engel J; Onitilo A
    Case Rep Oncol; 2020; 13(1):321-329. PubMed ID: 32308599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypercalcemia in malignancies of the female genital tract].
    Piura B
    Harefuah; 2008 Mar; 147(3):229-34, 277. PubMed ID: 18488865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM).
    Kobayashi N; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Tomimoto A; Yoneda K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A; Yamanaka S; Inayama Y
    J Hepatobiliary Pancreat Surg; 2008; 15(5):531-5. PubMed ID: 18836809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia of malignancy treated with cinacalcet.
    Asonitis N; Kassi E; Kokkinos M; Giovanopoulos I; Petychaki F; Gogas H
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 29399364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia: A Review.
    Walker MD; Shane E
    JAMA; 2022 Oct; 328(16):1624-1636. PubMed ID: 36282253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia of Malignancy.
    Malangone S; Campen CJ
    J Adv Pract Oncol; 2015; 6(6):586-92. PubMed ID: 27648348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital craniopharyngioma and hypercalcemia induced by parathyroid hormone-related protein.
    Brown JL; Burton DW; Deftos LJ; Smith AA; Pincus DW; Haller MJ
    Endocr Pract; 2007; 13(1):67-71. PubMed ID: 17360305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia in patients with oral squamous cell carcinoma.
    Iwase M; Kurachi Y; Kakuta S; Sakamaki H; Nakamura-Mitsuhashi M; Nagumo M
    Clin Oral Investig; 2001 Sep; 5(3):194-8. PubMed ID: 11642565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal parathyroid hormone-related protein-induced humoral hypercalcemia of malignancy in a 3-month-old infant.
    Lakhdir F; Lawson D; Schatz DA
    Eur J Pediatr; 1994 Oct; 153(10):718-20. PubMed ID: 7813527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercalcemia and Renal Mass: A Diagnostically Challenging Case.
    Karki S; Galiveeti S; Leung V
    Cureus; 2021 Jul; 13(7):e16718. PubMed ID: 34513354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
    Sato K; Onuma E; Yocum RC; Ogata E
    Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab Therapy for Refractory Hypercalcemia Secondary to Squamous Cell Carcinoma of Skin in Epidermolysis Bullosa.
    Giri D; Ramakrishnan R; Hayden J; Brook L; Das U; Mughal MZ; Selby P; Dharmaraj P; Senniappan S
    World J Oncol; 2015 Apr; 6(2):345-348. PubMed ID: 29147430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of humoral hypercalcemia of malignancy in metastatic cholangiocarcinoma.
    Lim S; Han J; Park KH; Jung WJ; Lee YK; Choi A; Kim YJ; Lee JC; Choi HJ
    Cancer Res Treat; 2013 Jun; 45(2):145-9. PubMed ID: 23864848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.